Nexalin Technology (NXL) Change in Cash (2021 - 2026)
Nexalin Technology (NXL) posted quarterly Change in Cash of $553112.0 for Q1 2026, up 1063.37% year-over-year from $47544.0 in Q1 2025, and up 754.78% quarter-over-quarter from $64708.0 in Q4 2025.
Nexalin Technology (NXL) Change in Cash (2021 - 2026) Analysis & Trends
Nexalin Technology's Change in Cash history runs 6 years deep, the most recent figure standing at $553112.0 for Q1 2026.
- In Q1 2026, Change in Cash rose 1063.37% year-over-year to $553112.0; the TTM figure through Mar 2026 stood at $585866.0 (up 673.18% YoY), while the FY2025 annual figure was $80298.0, up 1497.7% from the prior year.
- Change in Cash for Q1 2026 stood at $553112.0, up from $64708.0 in the prior quarter.
- The five-year high for Change in Cash was $7.6 million in Q3 2022, with the low at -$7.7 million in Q4 2022.
- The 5-year median for Change in Cash is $56761.0 (2023), against an average of $32124.5.
- The sharpest annual moves came in 2022 and 2026: Change in Cash plunged 1565.94% in 2022, then surged 1063.37% in 2026.
- Nexalin Technology's Change in Cash stood at -$7.7 million in 2022, then jumped by 102.84% to $218833.0 in 2023, then surged by 125.32% to $493064.0 in 2024, then tumbled by 86.88% to $64708.0 in 2025, then jumped by 754.78% to $553112.0 in 2026.
- Business Quant data shows NXL's Change in Cash at $553112.0 in Q1 2026, $64708.0 in Q4 2025, and $158755.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.07 Bn | 193.46 Bn | 7.27 Bn | -1.70 Bn |
| 2 | Stryker | 127.90 Bn | 124.43 Bn | 4.50 Bn | 513.00 Mn |
| 3 | Medtronic | 118.84 Bn | 109.62 Bn | 6.41 Bn | 803.00 Mn |
| 4 | Boston Scientific | 73.33 Bn | 72.79 Bn | 3.85 Bn | -890.00 Mn |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn | 462.20 Mn |
| 6 | Dexcom | 34.46 Bn | 32.51 Bn | 830.00 Mn | -13.20 Mn |
| 7 | GE HealthCare Technologies | 33.91 Bn | 31.81 Bn | 2.18 Bn | -180.00 Mn |
| 8 | Koninklijke Philips | 26.36 Bn | 23.04 Bn | 4.55 Bn | -1.21 Bn |
| 9 | Steris | 23.12 Bn | 22.64 Bn | 684.20 Mn | 42.80 Mn |
| 10 | Nexalin Technology | 6.98 Mn | 5.97 Mn | 8,897.00 | -202,937.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -202,937.00 |
| Mar 31, 2026 | 553,112.00 |
| Dec 31, 2025 | 64,708.00 |
| Sep 30, 2025 | 158,755.00 |
| Jun 30, 2025 | -190,709.00 |
| Mar 31, 2025 | 47,544.00 |
| Dec 31, 2024 | 493,064.00 |
| Sep 30, 2024 | -767,375.00 |
| Jun 30, 2024 | 302,541.00 |
| Mar 31, 2024 | -33,975.00 |
| Dec 31, 2023 | 218,833.00 |
| Sep 30, 2023 | 129,675.00 |
| Jun 30, 2023 | 56,761.00 |
| Mar 31, 2023 | 12,218.00 |
| Dec 31, 2022 | -7.70 Mn |
| Sep 30, 2022 | 7.57 Mn |
| Jun 30, 2022 | -167,272.00 |
| Mar 31, 2022 | -203,171.00 |
| Dec 31, 2021 | 525,352.00 |